These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 689736)

  • 81. In vitro inhibition of human peripheral blood lymphocyte transformation by an extract of Pseudomonas putida.
    Hunt CV; Khan W; Friedman G; Houck JC
    Immunology; 1977 Aug; 33(2):209-15. PubMed ID: 608686
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inhibitory effects of oral Actinomyces on the proliferation, virulence and biofilm formation of Candida albicans.
    Guo Y; Wei C; Liu C; Li D; Sun J; Huang H; Zhou H
    Arch Oral Biol; 2015 Sep; 60(9):1368-74. PubMed ID: 26143096
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Inhibiting effects of Streptococcus salivarius on competence-stimulating peptide-dependent biofilm formation by Streptococcus mutans.
    Tamura S; Yonezawa H; Motegi M; Nakao R; Yoneda S; Watanabe H; Yamazaki T; Senpuku H
    Oral Microbiol Immunol; 2009 Apr; 24(2):152-61. PubMed ID: 19239643
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Growth of oral Streptococcus species and Actinomyces viscosus in human saliva.
    de Jong MH; van der Hoeven JS; van OS JH; Olijve JH
    Appl Environ Microbiol; 1984 May; 47(5):901-4. PubMed ID: 6742834
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influence of oral bacteria on adhesion of Streptococcus mutans and Streptococcus sanguinis to dental materials.
    Nabert-Georgi C; Rodloff AC; Jentsch H; Reissmann DR; Schaumann R; Stingu CS
    Clin Exp Dent Res; 2018 Jun; 4(3):72-77. PubMed ID: 29955390
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Antimicrobial activity of N-alkylethylenediamines against oral and other microorganisms].
    Ueda M; Murata Y
    Yakugaku Zasshi; 1989 Mar; 109(3):184-7. PubMed ID: 2754620
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Degradation of starch and its hydrolytic products by oral bacteria.
    Glor EB; Miller CH; Spandau DF
    J Dent Res; 1988 Jan; 67(1):75-81. PubMed ID: 11039050
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cellular coaggregation of oral Streptococcus milleri with actinomyces.
    Eifuku H; Yakushiji T; Mizuno J; Kudo N; Inoue M
    Infect Immun; 1990 Jan; 58(1):163-8. PubMed ID: 2294047
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Detection of a fibroblast proliferation inhibitory factor from Capnocytophaga sputigena.
    Stevens RH; Sela MN; Shapira J; Hammond BF
    Infect Immun; 1980 Jan; 27(1):271-5. PubMed ID: 7358430
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inhibition of fibroblast proliferation by Actinobacillus actinomycetemcomitans.
    Shenker BJ; Kushner ME; Tsai CC
    Infect Immun; 1982 Dec; 38(3):986-92. PubMed ID: 7152684
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Suppression of fibroblast proliferation by oral spirochetes.
    Boehringer H; Taichman NS; Shenker BJ
    Infect Immun; 1984 Jul; 45(1):155-9. PubMed ID: 6735466
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Fractionation and characterization of the immunosuppressive substance in crude extracellular products released by Streptococcus intermedius.
    Arala-Chaves MP; Porto MT; Arnaud P; Saraiva MJ; Geada H; Patrick CC; Fudenberg HH
    J Clin Invest; 1981 Jul; 68(1):294-302. PubMed ID: 6454698
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.
    Ruoff KL
    Clin Microbiol Rev; 1988 Jan; 1(1):102-8. PubMed ID: 3060239
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius.
    Arala-Chaves MP; Higerd TB; Porto MT; Munoz J; Goust JM; Fudenberg HH; Loadholt CB
    J Clin Invest; 1979 Oct; 64(4):871-83. PubMed ID: 383749
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibitory effects of extracellular products from oral bacteria on human fibroblasts and stimulated lymphocytes.
    Higerd TB; Vesole DH; Goust JM
    Infect Immun; 1978 Aug; 21(2):567-74. PubMed ID: 689736
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inhibition of [3H]-thymidine uptake in human gingival fibroblasts by extracts from human dental plaque, oral bacteria of the Streptococcus and Actinomyces species.
    Duguid R
    Arch Oral Biol; 1985; 30(1):89-91. PubMed ID: 3857891
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Glucose uptake by Streptococcus mutans, Streptococcus mitis, and Actinomyces viscosus in the presence of human saliva.
    Germaine GR; Tellefson LM
    Infect Immun; 1982 Dec; 38(3):1060-7. PubMed ID: 7152663
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Peros WJ; Gibbons RJ
    Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selective binding of blood group-reactive salivary mucins by Streptococcus mutans and other oral organisms.
    Gibbons RJ; Qureshi JV
    Infect Immun; 1978 Dec; 22(3):665-71. PubMed ID: 310426
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.